23andMe provides DNA testing to assess genetic health risks, traits and ancestry.Other investors include: GlaxoSmithKline, NEA, Sequoia Capital, Johnson & Johnson, GV, Fidelity Learn more Back to Portfolio All, Exited/IPO, USADecacorn CapitalJuly 23, 2023Bio/Med Tech Facebook0 Twitter Pinterest0 0 Likes
